SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE

Pamela S. Douglas, MD; Amanda Stebbins, MS; Borek Foldyna, MD, PhD; Manesh R. Patel, MD; Daniel B. Mark, MD, MPH; Michael T. Lu, MD, MPH; Udo Hoffmann, MD, MPH; Svati H. Shah, MD, MHS; Beth Martinez, BS; Brooke Alhanti, PhD; Neha Pagidipati, MD, MPH

The research is a follow-up analysis of the PROMISE randomized clinical trial, which aimed to evaluate the effectiveness of different noninvasive testing strategies for coronary artery disease. Conducted over a median follow-up of 10.6 years, the study assessed mortality rates among participants who were randomized to receive either stress testing or CTA. The findings provide insights into the long-term implications of these testing methods on patient outcomes, particularly in terms of all-cause and cardiovascular mortality.